G and S Research Revenue and Competitors
Estimated Revenue & Valuation
- G and S Research's estimated annual revenue is currently $159.8M per year.
- G and S Research's estimated revenue per employee is $142,800
Employee Data
- G and S Research has 1119 Employees.
- G and S Research grew their employee count by -1% last year.
G and S Research's People
Name | Title | Email/Phone |
---|
G and S Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 14 | 8% | N/A | N/A |
#2 | $28.6M | 255 | 1% | N/A | N/A |
#3 | $3.6M | 44 | -8% | N/A | N/A |
#4 | $3.6M | 44 | 0% | N/A | N/A |
#5 | $77.3M | 606 | -6% | N/A | N/A |
#6 | $4.9M | 53 | -2% | N/A | N/A |
#7 | $5.3M | 58 | 12% | N/A | N/A |
#8 | $6.2M | 68 | 31% | N/A | N/A |
#9 | $6.3M | 69 | 6% | N/A | N/A |
#10 | $2.9M | 36 | 33% | N/A | N/A |
What Is G and S Research?
G & S Research provides primary market research services to pharmaceutical, biotech, medical device, and diagnostics firms worldwide. Offering a full range of qualitative and quantitative research services, the company custom-designs each study to address specific client and project objectives. G & S Research has a solid reputation for providing actionable information for its clients, and it is one of the most trusted and fastest growing research suppliers in the healthcare industry. The firm's deliverables are recognized not only for their analytical and reporting rigor but also for the presentation-ready formats in which they are provided. This provides clients with the insight and accuracy required to drive strategic business decisions.
keywords:N/AN/A
Total Funding
1119
Number of Employees
$159.8M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $435.8M | 1153 | 5% | N/A |
#2 | $35M | 1163 | 5% | N/A |
#3 | $289.5M | 1426 | 0% | N/A |
#4 | $553.8M | 1465 | 10% | N/A |
#5 | $249.1M | 1483 | 13% | N/A |